breast hyperplasia (liver stagnation and blood stasis type)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of mammary gland hyperplasia in Western medicine; (2) Meet the syndrome differentiation criteria of liver stagnation and blood stasis in traditional Chinese medicine; (3) Women aged 18-45 with regular menstrual cycle; (5) Informed consent, volunteer subjects and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant, lactating, perimenopausal women, intrauterine device users, severe menstrual cycle disorders such as hypogonadotropic menstrual disorders, hyperprolactinemia, polycystic ovary syndrome, patients with excessive menstrual flow anemia (Hb25mIU/ml. (7) Individuals with abnormal thyroid function. (8) Reproductive tract tumors affecting menstruation. (9) Patients with severe primary diseases such as heart, liver, kidney, and hematopoietic system, gastrointestinal ulcer disease, and mental illness; (10) Individuals with allergic constitution or allergic to the ingredients of this product; (11) Combined with severe acute and chronic infections and secondary kidney disease; (12) Pregnancy planning within 3 months; (13) Participants in other clinical trials within 3 months. (14) Suspected or confirmed history of alcohol or drug abuse, or other lesions or situations that, based on the researcher's judgment, reduce the likelihood of enrollment or complicate enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast lump;Breast pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual Traditional Chinese Medicine Symptom Score Table;Menstrual condition scoring table;Traditional Chinese Medicine Syndrome Score;Menstrual volume measurement (scoring by menstrual bleeding chart method); | — |
Countries
China
Contacts
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine